Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Sep 20, 2017, 11:16 ET Norgine lanza en Italia LYMPHOSEEK®▼ (99mTc-tilmanocept)

Norgine B.V. anunció hoy el lanzamiento en Italia de LYMPHOSEEK® (technetium Tc 99m tilmanocept). LYMPHOSEEK® es un radiofarmacéutico utilizado...


Sep 20, 2017, 11:03 ET Natera Selected for Circulating Tumor DNA Study in Bladder Cancer

Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Denmark's Aarhus University...


Sep 20, 2017, 10:48 ET Norgine führt LYMPHOSEEK®▼ (99mTc-tilmanocept) in Italien ein

Norgine B.V. hat heute die Einführung von LYMPHOSEEK® (Technetium Tc 99m tilmanocept) in Italien bekanntgegeben. LYMPHOSEEK® ist ein...


Sep 20, 2017, 10:36 ET Norgine lance LYMPHOSEEK®▼ (99mTc-tilmanocept) en Italie

Norgine B.V. a annoncé aujourd'hui le lancement de LYMPHOSEEK® (technetium Tc 99m tilmanocept) en Italie. LYMPHOSEEK® est un produit...


Sep 20, 2017, 10:31 ET New Peer-Reviewed Study Shows Pain Behavioral Health Program Participants Experienced Reductions in Depression Symptoms

AbleTo, Inc., the leading provider of technology-enabled behavioral health solutions proven to improve patient outcomes and lower healthcare costs,...


Sep 20, 2017, 09:02 ET DarioHealth Joins Philips-backed Innovation Hub HighTechXL to Empower More Diabetes Patients to Analyze and Personalize Their Treatment

DarioHealth Corp. (NASDAQ: DRIO), a smart diabetes solution, and HighTechXL, a corporate-backed accelerator based in Eindhoven, The Netherlands,...


Sep 20, 2017, 08:30 ET PharmaMar Starts Clinical Studies with a New Compound -PM14- in Patients with Solid Tumors

With the motivation of finding a solution to the unmet needs of patients with different types of cancer, PharmaMar (MCE:PHM) announces the start...


Sep 20, 2017, 08:18 ET Zavante Therapeutics To Present ZOLYD™ Data From Pivotal ZEUS Study At ID Week 2017

Zavante Therapeutics, Inc., a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients, and...


Sep 20, 2017, 08:00 ET Protagonist Therapeutics Announces Preliminary Phase 1 Study Results with Novel Hepcidin Mimetic, PTG-300

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today announced preliminary results from the Phase 1 study of PTG-300 in normal healthy volunteers....


Sep 20, 2017, 08:00 ET AOBiome Expands Intellectual Property Estate, Announces Issuance of U.S. Patent for Ammonia Oxidizing Bacteria (AOB) for the Treatment of Acne

AOBiome, a clinical-stage life sciences company advancing patented microbiome-targeted therapies for systemic and local inflammatory conditions,...


Sep 20, 2017, 07:24 ET Nektar Therapeutics Announces Seven Abstracts Accepted for Presentation at 2017 Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

Nektar Therapeutics (Nasdaq: NKTR) today announced that new data across its wholly-owned immuno-oncology (I-O) portfolio will be presented at the...


Sep 20, 2017, 07:00 ET The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy

The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI) today announced the first patients have begun treatment in a...


Sep 20, 2017, 06:49 ET Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

Edinburgh Molecular Imaging (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces it has...


Sep 20, 2017, 06:04 ET PharmaMar débute des études cliniques avec un nouveau composé, PM14, chez des patients atteints de tumeurs solides

Désireux de trouver une solution aux besoins insatisfaits des patients souffrant de différents types de cancer, PharmaMar (MCE: PHM) annonce le...


Sep 20, 2017, 06:00 ET Soligenix Announces $1.5 Million NIDCR SBIR Grant Award Supporting the Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...


Sep 20, 2017, 05:45 ET PharmaMar fa partire uno studio clinico con nuovo composto -PM14- nei pazienti con tumori solidi

Con l'obiettivo di trovare una soluzione alle esigenze senza risposta dei pazienti affetti da diversi tipi di cancro, PharmaMar (MCE: PHM)...


Sep 20, 2017, 05:42 ET PharmaMar startet klinische Studien mit einem neuen Präparat -PM14- bei Patienten mit soliden Tumoren

Mit der Motivation, eine Lösung für den unerfüllten Bedarf von Patienten mit unterschiedlichen Arten von Krebs zu finden, kündigt PharmaMar (MCE:...


Sep 19, 2017, 16:30 ET VolitionRx Announces its European Colorectal Cancer Strategy

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced its colorectal cancer (CRC) strategy for Europe. As part of its strategy,...


Sep 19, 2017, 16:24 ET Sepsis Power Hour - die Lösung für beschleunigte Pflege und reduzierte Behandlungskosten

Die Sepsis ist mit weltweit 18 Millionen Fällen pro Jahr die häufigste Todesursache in Folge einer Infektion und stellt mit einer Summe von 20...


Sep 19, 2017, 15:11 ET TSI completa su ensayo clínico de fase I sobre la innovadora terapia trombolítica TS01

El novedoso mecanismo de acción promueve una mayor seguridad y eficacia para el tratamiento de derrames cerebrales e infartos de miocardio...


Sep 19, 2017, 11:00 ET Oxitec to Build State-of-the-Art Mosquito Egg Production Unit

UK Prime Minister Theresa May Announces UK facility with Capacity to Generate One Billion Friendly™ Aedes Mosquito Eggs per Week Oxitec Ltd, a...


Sep 19, 2017, 10:30 ET Scientists Identify Key Regulator of Male Fertility

When it comes to male reproductive fertility, timing is everything. Now scientists are finding new details on how disruption of this timing may...


Sep 19, 2017, 10:24 ET MiMedx Files With The FDA To Initiate The Company's Investigational New Drug Phase 2 Clinical Trial For Osteoarthritis Of The Knee

MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing...


Sep 19, 2017, 10:20 ET AIVITA Biomedical Announces New Discovery with Applications to Regenerative Medicine, Skin Aging and Hair Growth

AIVITA Biomedical today announced the discovery of a new method for capturing and using intercellular signaling molecules to induce the...


Sep 19, 2017, 10:00 ET Morphotek To Present Preclinical Data On Antibody-Drug Conjugate MORAb-202 At The Upcoming 8th Annual World ADC In San Diego

Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it will present preclinical data on its investigational antibody-drug conjugate...